Close Menu

NEW YORK (GenomeWeb) — Centogene said today that it has launched a two-year study to investigate the genetic factors involved in Parkinson's disease in collaboration with the University of Lübeck in Germany.

The study — called the Rostock International Parkinson's Disease Study, or ROPAD — will enroll around 10,000 individuals worldwide and use Centogene's CentoCard dried blood spot collection kit to identify study participants with mutations in Parkinson's disease-associated genes including LRRK2 and GBA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.